These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7370919)

  • 1. Histologic features of tumors and the female superiority in survival from malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Apr; 45(7):1604-8. PubMed ID: 7370919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The female superiority in survival in clinical stage II cutaneous malignant melanoma.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1982 May; 49(9):1941-4. PubMed ID: 7074591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma: influence of site of lesion and age of patient in the female superiority in survival.
    Shaw HM; McGovern VJ; Milton GW; Farago GA; McCarthy WH
    Cancer; 1980 Dec; 46(12):2731-5. PubMed ID: 7448711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of the histological features of malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW; Farago GA
    Histopathology; 1979 Sep; 3(5):385-93. PubMed ID: 488922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Survival analysis in patients with cutaneous malignant melanoma].
    Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
    Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of a polypoid configuration in malignant melanoma.
    McGovern VJ; Shaw HM; Milton GW
    Histopathology; 1983 Sep; 7(5):663-72. PubMed ID: 6629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (less than or equal to 1.5 mm) melanoma.
    Kuehnl-Petzoldt C; Keil H; Schoepf E
    Arch Dermatol Res; 1984; 276(3):151-5. PubMed ID: 6476888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin level IV malignant melanoma. A subset in which level is the major prognostic indicator.
    Kelly JW; Sagebiel RW; Clyman S; Blois MS
    Ann Surg; 1985 Jul; 202(1):98-103. PubMed ID: 4015217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
    Cox NH; Aitchison TC; Sirel JM; MacKie RM
    Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status.
    MacKie RM; Hole DJ
    BMJ; 1996 May; 312(7039):1125-8. PubMed ID: 8620127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor thickness and prognosis in clinical stage I malignant melanoma.
    Karakousis CP; Emrich LJ; Rao U
    Cancer; 1989 Oct; 64(7):1432-6. PubMed ID: 2776106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival among patients with clinical stage I cutaneous malignant melanoma diagnosed in Western Australia in 1975/1976 and 1980/1981.
    Heenan PJ; English DR; Holman CD; Armstrong BK
    Cancer; 1991 Nov; 68(9):2079-87. PubMed ID: 1913557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
    Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
    Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
    Friedman RJ; Rigel DS; Kopf AW; Grin CM; Heilman E; Bart RS; Kamino H; Harris MN; Roses DF; Postel AH
    Dermatol Clin; 1991 Oct; 9(4):643-8. PubMed ID: 1934639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.